4.5 Article

Mitochondrial aconitase is a transglutaminase 2 substrate:: Transglutamination is a probable mechanism contributing to high-molecular-weight aggregates of aconitase and loss of aconitase activity in Huntington disease brain

Journal

NEUROCHEMICAL RESEARCH
Volume 30, Issue 10, Pages 1245-1255

Publisher

SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11064-005-8796-x

Keywords

Huntington disease; mitochondrial aconitase; non-synaptosomal mitochondria; transglutaminase

Funding

  1. NIA NIH HHS [P01 AG14930, AG19589] Funding Source: Medline
  2. NIMH NIH HHS [R24-MH 068855] Funding Source: Medline

Ask authors/readers for more resources

Transglutaminase activity was found to be present in highly purified non-synaptosomal rat brain mitochondria. A 78-kDa protein in these organelles was shown to be a transglutaminase 2 substrate, and incubation of a non-synaptosomal mitochondrial lysate with transglutaminase 2 yielded high-M-r proteins. The 78-kDa protein was identified as mitochondrial aconitase by MALDI-TOF analysis. Aconitase activity was decreased in a dose-dependent manner when non-synaptosomal rat brain mitochondria were incubated with transglutaminase 2. Transglutaminase activity is increased about 2-fold in the mitochondrial fraction of HD caudate. Moreover, Western blotting of the mitochondrial fraction revealed that most of the mitochondrial aconitase in HD caudate is present as high-M-r aggregates. Aconitase activity was previously shown to be decreased in Huntington disease (HD) caudate (a region severely damaged by the disease). The present findings suggest that an increase of transglutaminase activity in HD caudate may contribute to mitochondrial dysfunction by incorporating aconitase into inactive polymers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available